He is a practicing clinician-scientist, a neurologist, and directs the UC Irvine-MDA ALS and Neuromuscular Center. He is part of a national group of scientists who have identified the active genes in sporadic amyotrophic lateral sclerosis (ALS), a discovery that provides expanded opportunities for developing therapies to treat this chronic, incurable disease.